Cocreating local actions to make healthcare more rational
Cocreating Action to Improve Rationality in the Health System
NA · Universidad Miguel Hernandez de Elche · NCT07237971
This project will test whether working with residents in Elche to cocreate community actions can reduce unnecessary use of mental‑health drugs, cardiovascular medications, and antibiotics and ease pressure on primary care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 4000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universidad Miguel Hernandez de Elche (other) |
| Locations | 2 sites (Elche, Alicante and 1 other locations) |
| Trial ID | NCT07237971 on ClinicalTrials.gov |
What this trial studies
This mixed-methods project partners community members, pharmacies, and regional health services in Municipal District 2 of Elche to cocreate actions targeting psychological well‑being, cardiovascular risk management, and rational antibiotic use. Researchers will run a representative population survey, survey people collecting specified medications at participating community pharmacies, analyze aggregate prescription and primary-care consultation indicators from regional electronic systems, and conduct qualitative interviews and workshops. The cocreation process aims to design community-led interventions that reduce medicalisation, improve health equity, and lower demand on primary-care services.
Who should consider this trial
Good fit: Ideal participants are adults (18+) who live in Municipal District 2 of Elche or adults visiting participating community pharmacies in that district to collect antidepressants/anxiolytics, cardiovascular risk medications, or antibiotics.
Not a fit: People who live outside the district, those with complex or advanced conditions requiring ongoing specialist medication, or patients not engaged with local pharmacies or services are less likely to benefit directly.
Why it matters
Potential benefit: If successful, patients could face fewer unnecessary prescriptions, gain more community-based supports, and experience reduced strain and waiting times in primary care.
How similar studies have performed: Community cocreation and participatory approaches have shown promise for health promotion and antibiotic stewardship in some settings, but using them specifically to reduce medicalisation at the primary-care system level is relatively novel and less well established.
Eligibility criteria
Show full inclusion / exclusion criteria
Survey general population: A representative population survey of adult (aged 18 years and over) who are residents in the Municipal District 2 of Elche (Spain). Survey community pharmacies: Individuals who visit the pharmacies collaborating in the Municipal District 2 of Elche (Spain) to obtain any of the medications, aged 18 years and over for three a priori established medication groups. * Group 1 (Antidepressants and Anxiolytics): N05B, N05C, N06A. * Group 2 (Cardiovascular disease risk factor medication): A10B (antidiabetics), C10A (cholesterol-lowering drugs), C07A, C09A, C03C, C08C (antihypertensives). * Group 3 (Antibiotics): J01 Health service data from primary care: A series of aggregate indicators will be collected from the electronic information systems of the regional health authorities (Conselleria de Sanidad de la Generalitat Valenciana), which hosts information on both prescriptions made by physicians and those dispensed in the community pharmacies of the Valencian Community. These indicators will be calculated for individuals aged 18 years and over for groups 2 and 3, and 12 years and over for group 1 using aggregate data from health system's registries and, therefore, not considering 12 years old as minimum age limit of the eligible participants in the present study protocol registry. Furthermore, aggregate data about the number of consultations will be collected in the two primary care facilities in the study area for individuals aged 18 and over. Qualitative methods and cocreation procedure: Focus groups, sociograms and in-depth interviews will include 6-8 participants and last approximately 90 minutes. Participation in the co-creation process will be open, voluntary, and will depend on the interest of individuals and entities in the area. Eligibility criteria: * People aged 18 and over who are residents or have a job or family connection in the Municipal District 2 of Elche (Spain) who are interested in participating, wish to be actively involved in the co-creation, planning, and implementation of community initiatives, and are available to attend the conferences, meetings, and workshops. * Representatives from community institutions and associations, including professionals from the Elche Public Health Center, primary care teams in the area, Elche Council staff, as well as professionals and volunteers from NGOs and other local organizations with experience in community work in the district.
Where this trial is running
Elche, Alicante and 1 other locations
- Community — Elche, Alicante, Spain (RECRUITING)
- Community based. Municipal District 2 of Elche — Elche, Alicante, Spain (RECRUITING)
Study contacts
- Study coordinator: Lucy A Parker, PhD
- Email: cair@umh.es
- Phone: (0034)965919516
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Health-Related Quality-of-Life, Social Capital, Health Literacy, Community Based Participatory Research, Antibiotic Prescription, Mental Health Literacy, Cardio Vascular Disease, Antimicrobial Drug Resistance